Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the second quarter ended September 30, 2014. For the quarter, the company reported net sales of JPY 60,949 million against JPY 49,526 million a year ago. Operating income was JPY 4,410 million against JPY 3,718 million a year ago. Ordinary income was JPY 4,370 million against JPY 3,613 million a year ago. Net income was JPY 3,007 million against JPY 2,244 million a year ago. Net income per share was JPY 50.29 against JPY 56.32 a year ago. Diluted net income per share was JPY 50.25 against JPY 56.27 a year ago.

For the year ending March 31, 2015, the company expects net sales of JPY 123,000 million, operating income of JPY 9,300 million, ordinary income of JPY 9,000, and net income of JPY 5,900 million or net income per share of JPY 98.67.